← Open Payments lookup

EDWARD FRUITMAN: Open Payments

NPI 1558434134 · HEWLETT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$101,302 in 256 payments from 14 companies in 2025. Trend: 2023 $96,574 · 2024 $42,008 · 2025 $101,302

Speaker / faculty: $86,731Food & beverage: $6,121Consulting: $6,000Travel & lodging: $2,250Education: $201
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.54$33,176
E.R. Squibb & Sons, L.L.C.58$26,776
ABBVIE INC.55$22,695
Neurocrine BioSciences, Inc.29$17,556
Axsome Therapeutics, Inc.28$406
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$252
Takeda Pharmaceuticals U.S.A., Inc.1$103
Alkermes, Inc.4$76
Bausch Health US, LLC4$63
Corium, LLC3$51

Products named: UZEDY, COBENFY, VRAYLAR, INGREZZA, Auvelity, CAPLYTA, BOTOX, AUSTEDO XR.

Industry payments across NY — which companies pay providers there.